Project Grant R01MH139498
Award Date
4/3/25
Completion Date
1/31/30
Dollars Obligated
$736K
Federal Agency
National Institute of Mental Health
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Memphis, TN 38105, USA
Similar Awards
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is providing $731,035 to St. Jude Children's Research Hospital Inc. to conduct research on the neurological mechanisms underlying psychotic symptoms in 22q11.2 Deletion Syndrome, a genetic disorder that significantly increases the risk of schizophrenia.
The key objectives of the research are to: 1) Determine if mimicking the neurological abnormalities...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $423,500 to the University of Rochester to investigate the neural mechanisms underlying auditory hallucinations in schizophrenia. The primary objectives are to evaluate whether auditory hallucinations are associated with impaired auditory processing of speech and altered effects of prior knowledge on speech perception, using electroencephalography...
The National Institute of Mental Health (NIMH) awarded a $908,174 Project Grant (CFDA 93.242 - Mental Health Research Grants) to the Lieber Institute for Brain Development to conduct research entitled "Understanding Schizophrenia Risk Mechanisms via Multimodal Analysis of Patient-Derived Neurons and 3D Cortical Organoids and Correlation with Clinical and Cognitive Phenotypes." The project aims to utilize induced pluripotent stem cell (iPSC) technology and 3D cortical organoids to...
This National Institute of Mental Health (NIMH) Project Grant award under the Mental Health Research Grants program (CFDA 93.242) provides $1,677,954 to The Trustees of Columbia University in the City of New York to conduct translational research studies in humans and mice. The project aims to elucidate the circuit-level neurobiological mechanisms underlying auditory hallucinations, a core symptom of psychosis for which treatments are often ineffective. The research combines computational...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program provides $1,854,632 to The Children's Hospital of Philadelphia (CHOP) from July 2024 to January 2027. The project aims to study the role of mitochondrial function and synaptic activity in the development of schizophrenia, with a focus on iPSC-derived neurons from individuals with 22q11.2 deletion syndrome, a major genetic risk factor for schizophrenia. The...
The National Institute of Mental Health (NIMH) awarded a $429,000 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Thomas Jefferson University, doing business as Sidney Kimmel Medical College, to conduct cell type-specific analysis of SRC kinase-NMDA receptor complexes in schizophrenia.
The goal of this 2-year project is to determine how SRC kinase-mediated NMDA receptor signaling alterations differ between pyramidal neurons and interneurons in the postmortem dorsolateral...
The National Institute of Mental Health (NIMH) awarded a 5-year, $706,404 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to Thomas Jefferson University to study the pathophysiological roles of protein-protein interactions at excitatory synapses and their modifications in schizophrenia.
The key objectives are to examine how two specific protein-protein interactions altered in schizophrenia impact nanoscale molecular events to cause NMDA receptor hypofunction, and...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will fund a $464,750 investigation into the role of tandem repeat variation in the genetic risk of schizophrenia. The goal is to apply innovative algorithms for high-throughput tandem repeat genotyping to large, well-powered schizophrenia cohorts with whole genome sequencing data. This systematic study has the potential to uncover novel genetic risk...
This $388,800 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports a study to examine cognitive and psychiatric endophenotypes associated with rare genetic variants shared between autism spectrum disorder (ASD) and schizophrenia (SCZ). The study, led by researchers at The Trustees of Columbia University in the City of New York, will remotely assess cognition and psychopathology over two time points in...
This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $565,921 to the University of Texas Health Science Center at Houston (UTHealth) to conduct research on alternative stimulation modes and locations for the neuromodulation treatment of auditory hallucinations in individuals with schizophrenia spectrum disorders.
The study aims to test a novel approach to transcranial magnetic stimulation...